Brewin Dolphin Wealth Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Brewin Dolphin Wealth Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$357K	Hold	4,475	–	–	0.04%	103
2022 Q1	$471K	Hold	4,475	–	–	0.05%	100
2021 Q4	$482K	Sell	4,475 -525	-11%	-$57.3K	0.05%	98
2021 Q3	$548K	Hold	5,000	–	–	0.06%	89
2021 Q2	$468K	Hold	5,000	–	–	0.06%	97
2021 Q1	$460K	Buy	5,000 +100	+2%	+$8.44K	0.07%	92
2020 Q4	$358K	Hold	4,900	–	–	0.06%	92
2020 Q3	$381K	Sell	4,900 -800	-14%	-$55K	0.07%	90
2020 Q2	$317K	Hold	5,700	–	–	0.07%	90
2020 Q1	$169K	Hold	5,700	–	–	0.09%	71
2019 Q4	$206K	Hold	5,700	–	–	0.1%	74
2019 Q3	$155K	Hold	5,700	–	–	0.08%	82
2019 Q2	$137K	Buy	+5,700	New	+$145K	0.07%	85

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Brewin Dolphin Wealth Management's HZNP Position: Q2 2022 in Review

Brewin Dolphin Wealth Management held its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) position steady in Q2 2022 at 4,475 shares worth $357K. The position accounts for 0.04% of the portfolio, ranked #103.

Brewin Dolphin Wealth Management first reported a position in HZNP in Q2 2019 and has held it in 13 quarters since. The position peaked at $548K in Q3 2021. 616 funds tracked by Wall St. Rank hold HZNP as of Q2 2022.

Brewin Dolphin Wealth Management held 4,475 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $357K as of Q2 2022.
Brewin Dolphin Wealth Management left its Horizon Therapeutics Public Limited Company Ordinary Shares share count unchanged in Q2 2022.
Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.04% of Brewin Dolphin Wealth Management's portfolio in Q2 2022, its #103 holding.
Brewin Dolphin Wealth Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2019 and has held it in 13 quarters since.
Brewin Dolphin Wealth Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $548K in Q3 2021.
616 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2022.

Based on Brewin Dolphin Wealth Management's 13F filing for Q2 2022, filed 14 Nov 2022.